Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
30.62
-2.92 (-8.71%)
At close: Apr 1, 2025, 4:00 PM
30.50
-0.12 (-0.40%)
After-hours: Apr 1, 2025, 7:56 PM EDT

Crinetics Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Cash & Equivalents
264.5554.932.67200.793.09
Upgrade
Short-Term Investments
1,090503.66301.75133.0177.79
Upgrade
Cash & Short-Term Investments
1,354558.56334.43333.71170.88
Upgrade
Cash Growth
142.42%67.02%0.21%95.29%44.33%
Upgrade
Other Receivables
8.479.262.91.481.83
Upgrade
Receivables
8.479.262.91.481.83
Upgrade
Prepaid Expenses
10.434.563.517.21.72
Upgrade
Restricted Cash
0.5----
Upgrade
Other Current Assets
1.921.784.362.343.06
Upgrade
Total Current Assets
1,375574.15345.18344.72177.49
Upgrade
Property, Plant & Equipment
55.5857.434.994.725.41
Upgrade
Long-Term Investments
20.47-1.01-
Upgrade
Other Long-Term Assets
1.633.32.010.570.54
Upgrade
Total Assets
1,435635.35352.18351.02183.45
Upgrade
Accounts Payable
5.856.556.883.423.49
Upgrade
Accrued Expenses
44.4927.3517.1911.636.17
Upgrade
Current Portion of Leases
7.154.171.050.940.84
Upgrade
Current Unearned Revenue
2.182.062.24--
Upgrade
Other Current Liabilities
0.013.820.36--
Upgrade
Total Current Liabilities
59.6843.9427.721610.49
Upgrade
Long-Term Leases
44.5747.562.023.074.01
Upgrade
Long-Term Unearned Revenue
4.74.756.1--
Upgrade
Other Long-Term Liabilities
0.83--00.02
Upgrade
Total Liabilities
109.7996.2535.8519.0714.53
Upgrade
Common Stock
2,2761,192759.43607.58336.51
Upgrade
Retained Earnings
-952.11-653.7-439.17-275.26-167.61
Upgrade
Comprehensive Income & Other
0.960.98-3.93-0.380.03
Upgrade
Total Common Equity
1,325539.11316.33331.94168.92
Upgrade
Shareholders' Equity
1,325539.11316.33331.94168.92
Upgrade
Total Liabilities & Equity
1,435635.35352.18351.02183.45
Upgrade
Total Debt
51.7251.733.084.014.85
Upgrade
Net Cash (Debt)
1,302506.83331.35329.69166.03
Upgrade
Net Cash Growth
156.96%52.96%0.50%98.57%47.17%
Upgrade
Net Cash Per Share
16.128.736.378.585.45
Upgrade
Filing Date Shares Outstanding
93.0569.653.9147.7833.03
Upgrade
Total Common Shares Outstanding
92.9368.1853.8847.633
Upgrade
Working Capital
1,316530.21317.46328.73167
Upgrade
Book Value Per Share
14.267.915.876.975.12
Upgrade
Tangible Book Value
1,325539.11316.33331.94168.92
Upgrade
Tangible Book Value Per Share
14.267.915.876.975.12
Upgrade
Machinery
7.96.114.072.792.25
Upgrade
Leasehold Improvements
11.99.843.523.523.49
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q